Understanding how microRNAs affect addiction to stimulants and opioids
Micro-RNAs in Stimulant and Opioid Action
This study is looking at how tiny molecules in the brain, called microRNAs, affect how our brains respond to drugs like stimulants and opioids, which could help us understand addiction better and find new ways to treat it.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11158924 on NIH RePORTER |
What this research studies
This research investigates the role of specific microRNAs, particularly miR-132 and miR-212, in the brain's response to stimulant and opioid drugs. By examining how these microRNAs are regulated by microglia and the cytokine TNFα, the study aims to uncover mechanisms that influence drug-seeking behavior and addiction. The researchers will conduct experiments to observe how changes in microRNA signaling affect neuronal activity and behavior in response to drug exposure. This work could lead to new insights into the biological processes underlying addiction and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with stimulant or opioid addiction.
Not a fit: Patients who are not affected by stimulant or opioid addiction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for addiction that target microRNA signaling pathways.
How similar studies have performed: Previous research has shown promising results in understanding microRNA roles in addiction, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Kenny, Paul J. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Kenny, Paul J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.